138 patents currently held
5 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Jan 2030. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
2
Ending by 2030
Jan 2030
Next term end
130
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Jul 2039 · High confidence
Also notable
Ends Feb 2037 · High confidence
Also notable
Ends Jul 2038 · High confidence
Network, System and Method for Multi-View 3D Mesh Generation via Deformation
US 10,885,707
Cited by 8 later US patents, top 25% of utility patents granted in 2021 in our data. Protection runs to 2039.
Tissue Factor-Targeted Antibody-Drug Conjugate
US 11,534,495
Cited by 4 later US patents, top 25% of utility patents granted in 2022 in our data. Protection runs to 2037. A terminal disclaimer caps this term to an earlier patent's.
Polypeptide Eye Absorption Enhancer and Use Thereof
US 11,213,591
The newest of the three, granted 2022. It anchors the portfolio to 2038, later than anything else here.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 11, 2026The maintenance fee for Method of Synthesizing (1S, 5R)-LACTONE (US 10,316,012) comes due Dec 11, 2026. Unpaid by Jun 11, 2027, it lapses early.
- 4 fees due Jan 7 to 25, 2027 · next Jan 7
- 1 fee due Feb 20, 2027The maintenance fee for Semi-Floating-Gate Power Device and Manufacturing Method Therefor (US 10,388,650) comes due Feb 20, 2027. Unpaid by Aug 20, 2027, it lapses early.
- 4 fees due Mar 12 to 26, 2027 · next Mar 12
- 4 fees due Apr 1 to 30, 2027 · next Apr 1
- 3 fees due May 12 to 28, 2027 · next May 12
- 3 fees due Jun 5 to 26, 2027 · next Jun 5
- 5 fees due Jul 7 to 30, 2027 · next Jul 7
- 4 fees due Aug 20 to 27, 2027 · next Aug 20
- 2 fees due Sep 19 to 26, 2027 · next Sep 19
- 1 fee due Oct 7, 2027The maintenance fee for Method and Corresponding Reactor for Preparing Metal Nitrides with Adjustable Metal Contents (US 10,612,140) comes due Oct 7, 2027. Unpaid by Apr 7, 2028, it lapses early.
Recent changes
- Oct 9Assignment recorded on 1 record: Xu, Jianqing and 2 others to Fudan University Recorded Oct 9, 2026, executed Mar 17, 2026. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76326, frame 751.
- 4 of the patents on this record were granted since Aug 17, 2026
- 6 terms have ended since Aug 17, 2026
What they patent
The 5 largest of its 130 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Preparation Method for (R)-3-Hydroxyl-5-Hexenoate | 4 in force | to Feb 2039 |
| Network, System and Method for 3D Shape Generation | 3 in force | to Jul 2039 |
| Method for Synthesizing Diclofenac Sodium | 2 in force | to Feb 2043 |
| Polypeptide Eye Absorption Enhancer and Use Thereof | 2 in force | to Jul 2038 |
| Tissue Factor-Targeted Antibody-Drug Conjugate | 2 in force | to Feb 2037 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,071,934 | Method and System for Detecting Single-Shot Pulse Contrast Based on Fiber Array In force · High confidence | In force | High confidence | |
| US 8,895,237 | Enhancing of Hepatitis B Virus Vaccine and Its Gene In force · High confidence | In force | High confidence | |
| US 9,074,206 | Compositions and Methods for Micro-RNA Expression Profiling of Colorectal Cancer In force · High confidence | In force | High confidence | |
| US 8,698,082 | High-Fidelity Device for Single-Shot Pulse Contrast Measurement Based on Quasi-Phase-Matching (QPM) In force · High confidence | In force | High confidence | |
| US 9,658,052 | Method for Reducing Interference from Scattered Light/Reflected Light of Interference Path by Generating Carrier Through Phase In force · High confidence | In force | High confidence | |
| US 9,012,844 | Single-Shot Pulse Contrast Measuring Device Based on Non-Harmonic Long-Wavelength Sampling Pulse In force · High confidence | In force | High confidence | |
| US 9,796,732 | Pyridopyrimidine Or Pyrimidopyrimidine Compound, Prepration Method, Pharmaceutical Composition, And Use Thereof In force · High confidence | In force | High confidence | |
| US 10,086,067 | Pharmaceutical Composition for Viral Immunotherapy and Uses Thereof In force · High confidence | In force | High confidence | |
| US 10,024,697 | Method and System Using Wavelength Division Multiplexing for Eliminating and Reducing Light Diffusion and Light Reflection Interference in Interference Path In force · High confidence | In force | High confidence | |
| US 10,145,727 | Method and Structure for Diminishing Signal Interference of Transmission Path of Optical Fibre Interference System In force · High confidence | In force | High confidence |
Also on record, not counted in the 138: 5 patents in force now held by others · 69 patents ended · 93 applications pending · 86 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.